ArticleEuropean journal of haematology2026
Re: 'Cost-Effectiveness Analysis of Second-Line Lisocabtagene Maraleucel in the Treatment of Refractory or Relapsed Large B-Cell Lymphoma'.
Maajid Mohi Ud Din MalikPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.